CDKAL1 and obesity disorder: Among the 32 probesets, Scd1 is remarkable in that Scd1-deficient mice show the metabolic phenotypes in accordance with those observed in Cdkal1−/− mice; e.g., decreased susceptibility to diet-induced obesity, decreased plasma insulin level, and improved glucose tolerance [32].